Integrating network pharmacology and experimental models to identify notoginsenoside R1 ameliorates atherosclerosis by inhibiting macrophage NLRP3 …

J Yu, J Hu, M Baldini, H Lei, L Li, S Luo, J Wu… - Journal of Natural …, 2024 - Springer
Atherosclerosis is a cardiovascular disease, accounting for the most common mortality
cause worldwide. Notoginsenoside R1 (NGR1) is a characteristic saponin of Radix …